Soooooooo......the company outlines a calc that nominates funding for exactly 12.6 quarters, they states that the calc is not consistent with reality......and then...........
......well and then nothing.
What a freaking joke. Do they have any idea what they are going to spend? Talking up A$11.2M and (one assumes) not yet enrolled a candidate in a FDA P2 trial, FULLY FUNDED by the company - it seems they want they don't know or they prefer the market work out how much it will cost???!!!
I'll be watching. So will the BoDs, it seems.
Ann: Quarterly Activity Report & Appendix 4C, page-14
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $40.65M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 22.5¢ | $23.02K | 102.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33088 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 14 | 1 |
View Market Depth
| Last trade - 15.17pm 16/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |